{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T23:25:02Z","timestamp":1781047502480,"version":"3.54.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T00:00:00Z","timestamp":1578009600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T00:00:00Z","timestamp":1578009600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Care 4 Brittle Bones foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Osteogenesis Imperfecta (OI) is characterized by bone fragility, and features such as blue sclerae, dentinogenesis imperfecta, hearing loss, ligamentous laxity and short stature can be present. It has long been assumed that the functional ability and quality of life of patients with OI depends primarily on the severity of skeletal deformities. However, fatigue is often mentioned in clinic by patients with all types of OI as an important modifier of their quality of life and does not always seem to be related to their functional ability. The aim of this study is to investigate whether adults with Osteogenesis Imperfecta are significantly more fatigued than the normal population.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>The Fatigue Severity Scale (FSS) was distributed by mobile phone application among 151 adult patients with different OI types. Results of the FSS in the OI group were compared with two control populations from America (<jats:italic>n<\/jats:italic>\u2009=\u200920) and the Netherlands (<jats:italic>n<\/jats:italic>\u2009=\u2009113).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Ninety-nine patients (OI type 1 (<jats:italic>n<\/jats:italic>\u2009=\u200972), OI type 3 (<jats:italic>n<\/jats:italic>\u2009=\u200913), OI type 4 (<jats:italic>n<\/jats:italic>\u2009=\u200914) completed the FSS questionnaire. The mean FSS score of this cohort was 4.4 and significantly higher than the control populations (2.3\/2.9). 65% of our cohort reported at least moderate fatigue compared with 2 control populations from America and the Netherlands.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Fatigue in patients with OI is a frequently encountered problem in our expert clinic but research into this topic is sparse. This pilot study is the largest study to date investigating fatigue in patients with OI and results have been compared with two control groups. The mean FSS score of 4.4 in the OI group indicates that people with OI are generally significantly more fatigued than the control population. Further evaluation of fatigue and its influencers in a larger group of OI patients is important for future management.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12891-019-3000-7","type":"journal-article","created":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T18:03:26Z","timestamp":1578074606000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Fatigue in adults with Osteogenesis Imperfecta"],"prefix":"10.1186","volume":"21","author":[{"given":"Arjan G. J.","family":"Harsevoort","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7907-8887","authenticated-orcid":false,"given":"Koert","family":"Gooijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fleur S.","family":"van Dijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani\u00eblle A. F. M.","family":"van der Grijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton A. M.","family":"Franken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Marieke V.","family":"Dommisse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guus J. M.","family":"Janus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,3]]},"reference":[{"key":"3000_CR1","unstructured":"Steiner RD, Basel D. COL1A1\/2 Osteogenesis Imperfecta. [Updated 2019 Dec 12]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 2005. p. 1993\u20132019."},{"key":"3000_CR2","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1136\/jmg.16.2.101","volume":"16","author":"DO Sillence","year":"1979","unstructured":"Sillence DO, Senn A, Danks DM. Genetic heterogeneity in osteogenesis imperfecta. J Med Genet. 1979;16:101\u201316.","journal-title":"J Med Genet"},{"key":"3000_CR3","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1002\/ajmg.a.36545","volume":"164","author":"FSS Van Dijk","year":"2014","unstructured":"Van Dijk FSS, Sillence DOO. Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment. Am J Med Genet Part A. 2014;164:1470\u201381.","journal-title":"Am J Med Genet Part A"},{"key":"3000_CR4","doi-asserted-by":"crossref","unstructured":"Rauch F, Glorieux F. Ostegenesis Imperfecta. Lancet. 2004;363(9418):1377\u201385.","DOI":"10.1016\/S0140-6736(04)16051-0"},{"key":"3000_CR5","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.berh.2007.12.012","volume":"22","author":"FH Glorieux","year":"2008","unstructured":"Glorieux FH. Osteogenesis imperfecta. Best Pract Res Clin Rheumatol. 2008;22:85\u2013100.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"3000_CR6","doi-asserted-by":"crossref","unstructured":"Van Dijk FS, Byers PH, Dalgleish R, Malfait F, Maugeri A, Rohrbach M, Symoens S, Sistermans EA, Pals G. EMQN best practice guidelines for the laboratory diagnosis of osteogenesis imperfecta. Eur J Hum Genet. 2012;(1):11\u20139.","DOI":"10.1038\/ejhg.2011.141"},{"issue":"1","key":"3000_CR7","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1477-7525-12-54","volume":"12","author":"Claire L Hill","year":"2014","unstructured":"Hill CL, Baird WO, Walters SJ. Quality of life in children and adolescents with Osteogenesis Imperfecta: a qualitative interview based study. Health Qual Life Outcomes. 2014;12:54.","journal-title":"Health and Quality of Life Outcomes"},{"key":"3000_CR8","doi-asserted-by":"crossref","unstructured":"Tosi LL, Oetgen ME, Floor MK, Huber MB, Kennelly AM, McCarter RJ, Rak MF, Simmonds BJ, Simpson MD, Tucker CA, McKiernan FE. Initial report of the osteogenesis imperfecta adult natural history initiative. Orphanet J Rare Dis. 2015;10:146.","DOI":"10.1186\/s13023-015-0362-2"},{"key":"3000_CR9","doi-asserted-by":"crossref","unstructured":"Arponen H, Waltimo-Sir\u00e9n J, Valta H, M\u00e4kitie O. Fatigue and disturbances of sleep in patients with osteogenesis imperfecta - A cross-sectional questionnaire study. BMC Musculoskelet Disord. 2018;19(1):3.","DOI":"10.1186\/s12891-017-1922-5"},{"key":"3000_CR10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jpeds.2007.06.029","volume":"152","author":"M Van Brussel","year":"2008","unstructured":"Van Brussel M, Takken T, Uiterwaal CSPM, Pruijs HJ, Van der Net J, Helders PJM, Engelbert RHH. Physical Training in Children with Osteogenesis Imperfecta. J Pediatr. 2008;152:111\u20136 e1.","journal-title":"J Pediatr"},{"key":"3000_CR11","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1177\/1049909113494748","volume":"31","author":"J Finsterer","year":"2014","unstructured":"Finsterer J, Mahjoub SZ. Fatigue in healthy and diseased individuals. Am J Hosp Palliat Med. 2014;31:562\u201375.","journal-title":"Am J Hosp Palliat Med"},{"key":"3000_CR12","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0022-3999(03)00371-4","volume":"56","author":"AJ Dittner","year":"2004","unstructured":"Dittner AJ, Wessely SC, Brown RG. The assessment of fatigue: a practical guide for clinicians and researchers. J Psychosom Res. 2004;56:157\u201370.","journal-title":"J Psychosom Res"},{"key":"3000_CR13","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jpainsymman.2007.08.019","volume":"37","author":"L Whitehead","year":"2009","unstructured":"Whitehead L. The measurement of fatigue in chronic illness: a systematic review of unidimensional and multidimensional fatigue measures. J Pain Symptom Manag. 2009;37:107\u201328.","journal-title":"J Pain Symptom Manag"},{"issue":"10","key":"3000_CR14","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1001\/archneur.1989.00520460115022","volume":"46","author":"Lauren B. Krupp","year":"1989","unstructured":"Krupp LB, Larocca NG, Muir Nash J, Steinberg AD. The fatigue severity scale: Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46(10):1121\u20133.","journal-title":"Archives of Neurology"},{"issue":"8","key":"3000_CR15","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1212\/WNL.53.8.1648","volume":"53","author":"I. S. J. Merkies","year":"1999","unstructured":"Merkies IS, Schmitz PI, Samijn JP, van der Mech\u00e9 FG, van Doorn PA. Fatigue in immune-mediated polyneuropathies. European Inflammatory Neuropathy Cause and Treatment (INCAT) Group. Neurology. 1999;53(8):1648\u201354.","journal-title":"Neurology"},{"key":"3000_CR16","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.bonr.2018.04.009","volume":"8","author":"LJJ Scheres","year":"2018","unstructured":"Scheres LJJ, van Dijk FS, Harsevoort AJ, van Dijk ATH, Dommisse AM, Janus GJM, Franken AAM. Adults with osteogenesis imperfecta: clinical characteristics of 151 patients with a focus on bisphosphonate use and bone density measurements. Bone Reports Elsevier. 2018;8:168\u201372.","journal-title":"Bone Reports Elsevier"},{"issue":"7","key":"3000_CR17","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.jclinepi.2007.08.016","volume":"61","author":"Jacques Pouchot","year":"2008","unstructured":"Pouchot J, Kherani RB, Brant R, Lacaille D, Lehman AJ, Ensworth S, Kopec J, Esdaile JM, Liang MH. Determination of the minimal clinically important difference for seven fatigue measures in rheumatoid arthritis. J Clin Epidemiol. 2008;61(7):705\u201313.","journal-title":"Journal of Clinical Epidemiology"},{"key":"3000_CR18","unstructured":"Goligher EC, Pouchot J, Brant R, Kherani RB, Avi\u00f1a-Zubieta JA, Lacaille D, Lehman AJ, Ensworth S, Kopec J, Esdaile JM, Liang MH. Minimal clinically important difference for 7 measures of fatigue in patients with systemic lupus erythematosus. J Rheumatol. 2008;35(4):635\u201342."},{"issue":"2","key":"3000_CR19","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1080\/14034940410028406","volume":"33","author":"Anners Lerdal","year":"2005","unstructured":"Lerdal A, Moum T, Wahl AK, Rust\u00f8en T, Hanestad BR. Fatigue in the general population: A translation and test of the psychometric properties of the Norwegian version of the fatigue severity scale. Scand J Public Health. 2005;33(2):123\u201330.","journal-title":"Scandinavian Journal of Public Health"},{"issue":"11","key":"3000_CR20","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1093\/sleep\/31.11.1601","volume":"31","author":"Philipp O. Valko","year":"2008","unstructured":"Valko PO, Bassetti CL, Bloch KE, Held U, Baumann CR. Validation of the fatigue severity scale in a Swiss cohort. Sleep. 2008;31(11):1601\u20137.","journal-title":"Sleep"},{"key":"3000_CR21","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00223-017-0301-4","volume":"101","author":"JD Hald","year":"2017","unstructured":"Hald JD, Folkestad L, Harsl\u00f8f T, Brixen K, Langdahl B. Health-related quality of life in adults with Osteogenesis Imperfecta. Calcif Tissue Int Springer US. 2017;101:473\u20138.","journal-title":"Calcif Tissue Int Springer US"},{"issue":"8","key":"3000_CR22","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1002\/ajmg.a.36574","volume":"164","author":"Trine Bathen","year":"2014","unstructured":"Bathen T, Velvin G, Rand-Hendriksen S, Robinson HS. Fatigue in adults with Marfan syndrome, occurrence and associations to pain and other factors. Am J Med Genet Part A. 2014;164A(8):1931\u20139.","journal-title":"American Journal of Medical Genetics Part A"},{"key":"3000_CR23","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s13023-018-0905-4","volume":"13","author":"B Mueller","year":"2018","unstructured":"Mueller B, Engelbert R, Baratta-Ziska F, Bartels B, Blanc N, Brizola E, Fraschini P, Hill C, Marr C, Mills L, Montpetit K, Pacey V, Molina MR, Schuuring M, Verhille C, de Vries O, Yeung EHK, Semler O. Consensus statement on physical rehabilitation in children and adolescents with osteogenesis imperfecta. Orphanet J Rare Dis BioMed Central. 2018;13:158.","journal-title":"Orphanet J Rare Dis BioMed Central"},{"issue":"4","key":"3000_CR24","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1177\/1352458509360040","volume":"16","author":"U. Dalgas","year":"2010","unstructured":"Dalgas U, Stenager E, Jakobsen J, Petersen T, Hansen HJ, Knudsen C, Overgaard K. Fatigue, mood and quality of life improve in MS patients after progressive resistance training. Mult Scler. 2010;16(4):480\u201390.","journal-title":"Multiple Sclerosis Journal"},{"issue":"6","key":"3000_CR25","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/j.1365-2648.2006.04054.x","volume":"56","author":"Jane Neill","year":"2006","unstructured":"Neill J, Belan I, Ried K. Effectiveness of non-pharmacological interventions for fatigue in adults with multiple sclerosis, rheumatoid arthritis, or systemic lupus erythematosus: a systematic review. J Adv Nurs. 2006;56(6):617\u201335.","journal-title":"Journal of Advanced Nursing"},{"issue":"4","key":"3000_CR26","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1034\/j.1399-0004.2001.600405.x","volume":"60","author":"KF Peters","year":"2002","unstructured":"Peters KF, Kong F, Horne R, Francomano CA, Biesecker BB. Living with Marfan syndrom I. Perceptions of the condition. Clin Genet. 2001;60(4):273\u201382.","journal-title":"Clinical Genetics"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-019-3000-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12891-019-3000-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-019-3000-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T00:13:08Z","timestamp":1609546388000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-019-3000-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,3]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3000"],"URL":"https:\/\/doi.org\/10.1186\/s12891-019-3000-7","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,3]]},"assertion":[{"value":"25 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was registered in the Isala research registry (Nr.190106) and the local Medical Ethical Committee approved the study protocol and granted an exemption because participants are not subject to procedures or are required to follow rules of behavior. A signed informed consent was obtained from each participant.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}